Pre-digest of unprotected DNA by Benzonase improves the representation of living skin bacteria and efficiently depletes host DNA
Microbiome volume 9, Article number: 123 (2021)
The identification of microbiota based on next-generation sequencing (NGS) of extracted DNA has drastically improved our understanding of the role of microbial communities in health and disease. However, DNA-based microbiome analysis cannot per se differentiate between living and dead microorganisms. In environments such as the skin, host defense mechanisms including antimicrobial peptides and low cutaneous pH result in a high microbial turnover, likely resulting in high numbers of dead cells present and releasing substantial amounts of microbial DNA. NGS analyses may thus lead to inaccurate estimations of microbiome structures and consequently functional capacities.
We investigated in this study the feasibility of a Benzonase-based approach (BDA) to pre-digest unprotected DNA, i.e., of dead microbial cells, as a method to overcome these limitations, thus offering a more accurate assessment of the living microbiome. A skin mock community as well as skin microbiome samples were analyzed using 16S rRNA gene sequencing and metagenomics sequencing after DNA extraction with and without a Benzonase digest to assess bacterial diversity patterns. The BDA method resulted in less reads from dead bacteria both in the skin mock community and skin swabs spiked with either heat-inactivated bacteria or bacterial-free DNA. This approach also efficiently depleted host DNA reads in samples with high human-to-microbial DNA ratios, with no obvious impact on the microbiome profile. We further observed that low biomass samples generate an α-diversity bias when the bacterial load is lower than 105 CFU and that Benzonase digest is not sufficient to overcome this bias.
The BDA approach enables both a better assessment of the living microbiota and depletion of host DNA reads.
The human skin constitutes an essential physical, chemical, and immunological barrier to the surrounding environment. It is covered by commensal microbiota, which contribute to the health of their host. In cases of dysbiosis, however, the microbiome can facilitate the colonization of the skin with facultative or obligate pathogens and, thus, initiate or exacerbate various skin diseases [1, 2]. Therefore, the analysis of skin microbiota is important for elucidating the still unclear etiologies of many skin disorders with likely microbial involvement, like atopic dermatitis [3,4,5], psoriasis [6, 7], or acne vulgaris .
The use of cultivation-independent 16S rRNA gene sequencing to analyze the composition of the skin microbiome has drastically facilitated this task and yielded a wealth of new insights, even though various concerns about validity of the output have been raised . Inevitably, this approach is strongly dependent on the quality of the microbial DNA analyzed. The DNA extraction protocol therefore plays a crucial role in the final outcome. Nevertheless, most of the available protocols for bacterial DNA extraction from human specimens have been originally designed to analyze soil microbiota . They are also sufficiently and widely used to prepare DNA for analyses of stool microbiomes, since both sample types contain large amounts of microbes and require removal of PCR inhibitors . In contrast, microbial biomass is rather low on the skin due to cutaneous low pH and permanent secretion of antimicrobials . This makes the extraction of microbial DNA from skin samples far more challenging, and optimizations of the extraction and sequencing protocols are still needed .
In addition to the low microbial DNA content, high ratios of human-to-microbial DNA have been reported for skin swabs  and various other clinical specimens, such as sputum , saliva , oral samples , and vaginal samples . Human-to-microbe DNA ratios can even increase when samples are taken from inflamed or infected sites because of immune cell influx, tissue wounds, or necrosis . Depending on the primers used to amplify the 16S rRNA gene region of choice, a strong bias may be introduced by co-amplification of non-target DNA; especially human mitochondrial 16S rRNA genes can be preferentially amplified due to their high loads . Metagenome analyses of such samples are also challenging since host DNA reads can drown microbial reads, leading to a drastic increase of costs because of the higher sequencing depth required.
Several strategies have been proposed to optimize DNA preparation from samples low in microbes. For instance, methylated CpG-poor DNA is depleted to concentrate microbial DNA . Other approaches employ a pre-lysis step of host cells followed by DNase digestion prior to the extraction of microbial DNA. The latter approach yielded promising results when applied on samples from resected arthroplasty components  or saliva . Nevertheless, while these reports have proven that human DNA concentrations in microbial DNA preparations can be reduced, the elimination of DNA from dead microbiota has been neglected thus far, and the impact on community structure and functional characteristics deduced from dead microbes remains unclear. Therefore, selectively analyzing only living microorganisms might lead to a less biased interpretation of microbial communities’ composition and their active metabolic processes on the skin .
The aim of this study was to evaluate the ability of a DNA pre-digest approach using Benzonase to improve the representation of living skin microbiota in sequencing reads [23, 24] and to deplete host DNA. Benzonase removes host DNA and unprotected microbial DNA because of its broad activity towards DNA substrates, which it cleaves into short fragments of ≤ 5 nucleotides in length that cannot be amplified anymore. A slight preference for G/C-rich segments has been reported, but since the digest is performed before lysis of intact bacteria, no bias to the living microbiome should be introduced into analysis [23, 24]. Finally, we evaluated the impact of this approach on microbiome profiles and assessed its ability to reduce the diversity bias that might be generated in low biomass samples such as skin swabs. We demonstrated the optimized protocol to allow a more accurate interpretation of microbiome composition. This might enable a better assessment of host–bacteria interactions, since it is only the living fraction of the microbiome that can proliferate and adapt to shape a given environment.
DNase digest prior to microbial lysis efficiently depletes unprotected DNA of dead bacteria in a skin microbiome mimicking mock community and in skin microbiome samples
The cutaneous surface provides a tough environment for its inhabiting microorganisms. Dryness, acidic pH, sparse nutrients, and antimicrobials produced by the host and competing microorganisms alike efficiently limit the quantity of bacteria living on the skin [12, 25, 26]. The resulting low bacterial DNA yield from skin samples represents a major challenge when analyzing the skin microbiome. In contrast to high microbial biomass samples (e.g., feces), any contamination from kit reagents or the laboratory environment might be prominently represented [27, 28].
We used a skin mock community to test whether DNA digest prior to bacteria lysis might improve the outcome of 16S rRNA gene sequencing by removing reads originating from dead bacteria or contaminant-free DNA. This mock community was comprised of ten species belonging to six different genera commonly isolated from human skin and representative of the three skin-dominant bacterial phyla: Firmicutes, Actinobacteria, and Proteobacteria. Species typically isolated from the antecubital crease (Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus hominis, and Micrococcus luteus) were included because the area is a predilection site of atopic dermatitis. This disease is an intensely studied inflammatory skin disorder with a still enigmatic role of lesional skin microbiota , which are not only seen as drivers of disease exacerbation but also contributors of anti-inflammatory stimuli [30,31,32]. Furthermore, typical skin-resident bacteria such as Corynebacterium pseudodiphthericum, Corynebacterium striatum, and Bacillus horneckiae as well as bacteria that can be found on the skin at lower abundance, like Escherichia coli, Pseudomonas aeruginosa, and Proteus mirabilis, were included. We added 107 CFU of each bacterium to the mix to obtain final samples of 108 CFU referred to as the “live” mock community. To also simulate the presence of dead bacteria, all strains were included alive except P. aeruginosa and P. mirabilis, which were added after heat inactivation (1 h at 56 °C) to the “hi” variant of the mock community. In addition, to investigate consequences of extracellular DNA, the “hi DNA” mock community consisted of the “hi” mock community, with added purified Bacillus simplex DNA corresponding to 107 CFU (see Table 1).
We then compared 16S rRNA gene sequencing data after DNA extraction using the QIAamp DNA Microbiome kit, preceded (BDA) or not (NDA) by a Benzonase digest that removed all DNA not protected by an intact bacterial cell envelope. Although bacteria have been added at similar initial loads, OTU’s relative abundances obtained from amplified 16S RNA genes differed considerably (BDA / NDA live; Fig. 1a and b, left). This is likely due to differences in 16S rRNA gene copy numbers between bacterial species as well as varying susceptibilities to mechanical and enzymatic lysis during bacterial DNA extraction. When P. aeruginosa and P. mirabilis cells were heat inactivated, reads from these bacteria sharply declined in BDA-processed samples and their relative abundances dropped from 17.75 ± 0.13% (P. aeruginosa) and 17.83 ± 2.91% (P. mirabilis) to 0.041 ± 0.03% and 0.99 ± 0.09%, respectively (hi; Fig. 1a, middle; Fig. 1c and d). Application of the BDA to the hi DNA mock community resulted in virtually complete degradation of the extracellular DNA (0.001% remaining reads from B. simplex). In contrast, the extracellular DNA in the hi DNA mock community was mostly unaffected by the NDA (Fig. 1a, right; Fig. 1b, right; Fig. 1e). This demonstrates that DNA originating either from dead bacteria or free bacterial DNA was efficiently removed, which otherwise would result in similar operational taxonomic unit (OTU) read numbers (i.e., a similar microbiome composition) as seen with NDA samples prepared without pre-digest (Fig. 1b–e). Interestingly, depletion of dead bacteria and free bacterial DNA led to distinct clustering in a principal coordinate analysis (PCoA; Fig. 1f), demonstrating that the presence of large amounts of dead bacteria within microbiome samples introduced a bias into data interpretations in terms of structure and functionality.
We verified these results by comparing BDA with a different and more conventional microbiome DNA preparation approach using the ZymoBiomics DNA miniprep kit without any pre-digest (CA). To this end, we analyzed a smaller skin mock community (Fig. S1a) and a microbiome suspension prepared from a human antecubital crease swab (Fig. S1c). These preparations were spiked either with 106 heat-inactivated E. coli cells or 4.2 ng of purified E. coli DNA. As expected, OTU reads matching to E. coli dominated the 16S rRNA gene analysis of CA-prepared samples in both cases. In contrast, BDA led to strong reduction of reads from either dead E. coli cells or its free DNA (Fig. S1b, d).
Taken together, BDA improves the representation of bacterial taxa truly present and alive in skin swabs and other low microbial density samples. Noteworthy, the additional preparation steps introduced to perform Benzonase digest in BDA did not result in any other obvious microbial DNA contamination.
Human DNA is efficiently depleted by the BDA approach with no impact on the microbiome profile
Next, we evaluated the effectiveness of BDA to remove host DNA before preparing microbial DNA. Total DNA yields from mock community samples with heat-inactivated P. aeruginosa and P. mirabilis bacteria, supplemented with purified B. subtilis DNA and human 105 PBMCs, decreased from 28.33 ± 3.68 ng/μl in samples processed with NDA to 1.95 ± 0.3 ng/μl with BDA (Fig. 2a). Strikingly, human DNA reads found in whole metagenome analysis were significantly reduced by BDA to 0.37 ± 0.08% from formerly 80.88 ± 0.51% with NDA (Fig. 2b), indicating an efficient removal of host DNA from microbiome samples following host cell lysis and Benzonase digest. Confirming this result, BDA also diminished DNA yields compared with CA. The latter retained roughly the same amount of host DNA compared with an approach designed for DNA preparation from human blood cells (HA; Fig. S2a, b).
Importantly, the taxonomic binning at OTU level of 16S rRNA gene sequencing data did not reveal any notable changes in analyzed skin mock communities (containing heat-inactive bacteria and free bacterial DNA) supplemented or not with PBMCs and processed with BDA (Fig. 2c, middle and right). Similarly to 16S rRNA gene based sequencing (Fig. 2c and d), the community profiling using the metagenomics approach had also shown a drastic decrease of dead bacteria and complete depletion of free bacterial DNA following BDA (Fig. S3c, d). In addition, the PCoA plot of β-diversity showed strong shifts in microbiome structure when adding heat-inactivated bacteria and free bacterial DNA, but no effect exerted by the supplementation of PBMCs was observed (Fig. S2c). We conclude that the Benzonase digest step following host cell lysis in the BDA efficiently depletes host DNA as well as unprotected bacterial DNA with no significant impact on the viable microbiota fraction. Therefore, although the relative abundance of reads resulting from intact bacteria is not affected, information will still be lost if reads are wasted on human DNA.
Low biomass microbiome samples result in a biased α-diversity estimation
The low bacterial DNA content of low microbiome input samples such as skin swabs poses the danger of artificially increased diversity, i.e., the appearance of OTUs in sequencing results that do not originate from sampled microbiomes can be a crucial confounder [33,34,35]. To assess any introduced diversity bias, we analyzed 16S rRNA gene reads in dilution series of the skin mock community. For both BDA and NDA, we observed an increase of microbial α-diversity upon sample dilution. In 1:1000 diluted samples (i.e., 105 CFU), contaminations still had a minor effect when prepared by BDA, only becoming significant for samples at or below 103 CFU. At this point, numerous bacterial OTUs appeared that had not been included into the original mock community (Fig. 3a and b). In line with this finding, sequencing the sterile water control samples showed the highest number of OTUs. An even stronger increase in bacterial richness (i.e., number of OTUs) was observed with NDA, reaching a significant difference at 105 CFU (Fig. 3c and d). Similarly, the Shannon index increased in both approaches, with significant differences achieved at the ultimate dilution (103 CFU) (Fig. 3e and f).
PCoA showed that β-diversity of diluted samples shifted upon dilution, with PCoA1 accounting for about 70% of differences in both approaches. The microbiome composition was independent from the influence of dilution or contaminants when the bacterial load was equal to or higher than 105 CFU (Fig. 3g and h). However, in comparison to samples processed by the CA, BDA showed a higher stability in terms of α- and β-diversity upon serial dilutions (Fig. S4). In samples processed by the CA, α-diversity was generally higher than in BDA samples, e.g., in the 105 CFU samples richness was more than twice as high (Fig. S4c, d). This difference resulted in a distinct microbial profile which clustered remote from the BDA-processed mock community samples in multidimensional scaling (MDS) for the β-diversity, similar to the 100 times more diluted 103 CFU sample after BDA preparation (Fig. S4g, h). The BDA, therefore, resulted in α-diversity values closer to the original bacterial community, especially when samples contained numbers of bacteria typically obtained from skin swabs (in our experience ≤ 105 CFU/sample if sampled skin area is not strongly infected).
We additionally performed a relative abundance analysis for each species present in the diluted mock community, processed with either the BDA (Fig. 4a) or NDA (Fig. 4b). Results showed stable or decreased relative abundance values of nearly all bacterial members of the mock community upon dilution irrespective of the approach used. However, S. epidermidis reads, which were highly abundant in the control samples (up to 20% in BDA and 30% in NDA), increased upon dilution. S. aureus was also present at a high relative abundance of about 12.5% in both controls, while C. striatum was detected at lower abundance (3%). Interestingly, P. mirabilis was exclusively present in the NDA control samples, indicating that it was introduced before Benzonase pre-digest. Additionally, spurious reads of OTUs not present at all in the original mock community made up 36.53% and 40.20% of all reads in the BDA and NDA-processed samples with 103 CFU, respectively (Tables S1 and S2). Most of the contaminants detected at this dilution were either typical environmental bacteria like Arenibacter nanhaiticus or Undibacterium oligocarboniphilum, which has been isolated from purified water . In lower proportions, we also detected reads belonging to the genera Propionibacterium, Corynebacterium, Streptococcus, and Lactobacillus.
However, in either approach, the number of contaminating reads was lower compared with that in the CA. This comparison between kits has been added to assess the effect of factors other than Benzonase pre-digest, e.g., of kit purity when performing microbial DNA extraction from low biomass samples. In the CA, up to 80% reads belonged to contaminants in the 103 CFU dilution of the mock community (Tables S3 and S4). This is in line with studies reporting that kit reagents are a potential source of bacterial DNA contamination, which is especially relevant in low biomass or diluted microbiome samples [35, 37,38,39]. Most of the contaminating bacterial OTUs found are from species ubiquitously present in soil and water. They are apparently able to contaminate the DNA extraction kits during production at different abundances depending on the manufacturing process. In contrast, contaminations introduced by sampling, the PCR or the performing lab seem to play a rather minor role compared with kit contaminants, as only 7 of 34 contaminating OTUs appeared in any BDA sample and 7 of 38 in any CA sample. These contaminations seem to be very low, since not all OTUs found in the kit controls were also observed in samples using 103 CFU.
The human microbiome plays a central role in host health and disease. Dysbiotic shifts of its composition have been linked to the genesis and progression of a wide variety of diseases, such as atopic dermatitis, psoriasis, asthma, colitis, and obesity [6, 40,41,42,43]. Various techniques have been developed for characterizing the microbiome, but approaches that employ NGS, like 16S rRNA gene sequencing or metagenome analyses, have gained increasing interest by achieving this goal at ever lower costs and unchallenged accuracy so far [39, 44]. However, most protocols for DNA isolation do not discriminate between DNA of viable and dead bacteria, thus introducing a bias into NGS-based analysis results . This limitation significantly affects the data and may lead to misinterpretations, since the structure and functions of microbiomes are strongly linked to the vitality of their community members .
Removal of DNA from dead bacteria
We investigated the feasibility of a Benzonase-based approach to pre-digest unprotected DNA to overcome these limitations and thus offer a better assessment of the living microbiome. On the downside, this approach adds almost 2 hours of incubation and hands-on time in addition to requiring freshly prepared samples to avoid bacterial lysis by freezing. We focused on skin samples because their microbiome is challenging to analyze due to the low numbers of bacteria present [47, 48]. BDA not only completely removed purified B. simplex DNA but also drastically reduced reads in the final data originating from heat inactivated bacterial cells spiked into the mock community (P. aeruginosa, P. mirabilis) and skin samples (E. coli). Originally designed to remove unwanted human reads in metagenome sequencing by host cell pre-lysis followed by DNA digest, BDA therefore noticeably decreases reads from dead bacterial cells and free DNA. This improves the characterization of the living microbiome by both 16S rRNA gene and metagenomics sequencing.
One of the major advantages of assessing the living microbiome is that it enables a more accurate interpretation of host–bacteria interactions. The structure and function of the microbiomes is mainly dependent on members of the community that are alive. Certainly, microbes without intact cell walls can be considered dead, but they can constitute a large fraction of the OTU reads in sequencing based approaches . Occasionally, bacteria enter a state called viable but not culturable (VBNC) . Such cells may not be active members of the microbiome at the time of sampling and will not be detected by culture-based methods, but they may still be important in earlier or later stages of a disease. Therefore, it would be often desirable to link the detected microbial species with quantitative data of their metabolic activity, since we expect BDA not to digest DNA of still intact VBNC cells. Methods for the detection of metabolic activities cannot be easily applied to low biomass samples, however, and do not yet enable reliable assessment of metabolic activity .
Host DNA removal
An additional advantage of BDA is removal of host DNA reads. It has been reported that metagenomes of human stool samples contain usually less than 10% of reads mapping to the host’s genome, while skin, nasal cavity, vaginal, and sputum samples yield up to 90% of human reads . Remarkably, BDA works without affecting the microbiome profile in terms of α- or β-diversities. Indeed, our metagenomics data analysis revealed a drastic and significant decrease of host DNA reads from 81 to 0.37% when using BDA, thereby increasing bacterial reads in these samples with high human DNA load to up to 99.63%. Corroborating our results, Nelson et al.  have shown a noticeable decrease of human and extracellular DNA reads following a Benzonase digest in sputum samples, which dropped from 96% with the standard extraction method to 60%, along with an up to 15-fold increase of bacterial reads.
Efficient depletion of host DNA is of great importance in metagenomics analysis, since host DNA generates immense amounts of unwanted reads. Some protocols rely on the viability PCR method, using ethidium monoazide (EMA) or propidium monoazide (PMA) staining to mitigate this problem [15, 46, 51]. These dyes penetrate damaged cells to intercalate with their DNA. Exposed to blue light, the dyes form covalent bonds, preventing DNA amplification [52,53,54]. However, these dyes have been shown to penetrate various intact bacteria, including E. coli, Staphylococcus aureus, Streptococcus sobrinus, and Mycobacterium avium , and display antimicrobial effects as observed for Listeria monocytogenes and Legionella pneumophila [56, 57]. Finally, penetration of living bacterial cells can vary depending on their physiological state (e.g., the uptake is increased in rapidly dividing cells compared to senescent cells) . Furthermore, Nelson et al.  argued that the efficiency of PMA is limited to the amplification of long targets (amplicon sequencing), while metagenomics sequencing may yield smaller fragments, which are less affected. In another study, however, combining host cell lysis with PMA treatment to process human saliva samples, Marotz et al. have shown an effective removal of host-derived sequencing reads from about 90% in untreated samples down to about 9% after treatment . Thus, PMA might be useful under some circumstances, while BDA seems to be more effective and more robust for different sample and analysis types.
Concerning microbial diversity, we demonstrated that contaminating bacterial DNA might considerably affect microbiome profiles. We have observed increasing values of α-diversity in samples prepared by both BDA and NDA upon serial dilutions. Increased diversity was more obvious in low bacterial input samples containing 103 CFU for both BDA and NDA, while CA showed large numbers of non-sample OTUs already when the number of bacteria in the sample was two orders of magnitude higher (105 CFU). These results were concordant with the β-diversity data plots, which display stronger shifts of the diluted CA samples compared to the diluted BDA-samples towards the control’s position. Two principal sources of contamination have been reported in microbiome studies: contaminant DNA and cross-contamination . Contaminating DNA can originate from various sources, including sampling procedures and environments [38, 59, 60], DNA extraction kits [34, 35], and laboratory reagents like PCR master-mixes . Cross-contamination occurs from other adjacent samples, sequencing runs, and barcode leakage . Our data indicate that kits or reagents play an important role in the contamination of low biomass samples processed here. This contamination distorts microbiome analysis. The BDA did not reduce the appearing α-diversity bias for highly diluted samples, but lower contamination introduced by reagents and consumables used in both BDA and NDA resulted in much better results compared with the CA approach. Thus, a careful analysis and interpretation of microbial diversity is needed, especially when working with low biomass samples such as skin, lung, or blood samples .
For instance, the α-diversity interpretations in chronic skin pathologies, like atopic dermatitis, should be reconsidered, since the low diversity observed in lesional skin samples could be due to a high number of reads from one bacterial species (S. aureus in this case), which dilutes out any other OTUs still present, albeit at much lower abundances. On the other hand, based on the noted increase of diversity upon serial dilutions, one can imagine that the high α-diversity observed on the skin of healthy controls in many microbiome studies might at least partially be due to the low number of bacteria captured from the hostile cutaneous environment. To ensure highly reliable results from samples with very low bacteria content, collecting the maximum sample amount is critical. Furthermore, it might be feasible and helpful in some studies to quantify the bacterial number in samples by counting bacteria cultured from a fraction of the sample or by qPCR quantification to exclude samples with too low bacterial content (i.e., ≤ 103 CFU/sample).
In this study, we examined the ability of a Benzonase-based approach for microbial DNA extractions to improve the representation of living microorganisms in human skin microbiome samples. This method successfully decreased read numbers from dead bacteria or extracellular DNA. The BDA approach efficiently depleted host DNA reads with no significant impact on the microbial profile in metagenomes. Moreover, we have shown that more diluted samples from mock communities (i.e., with very low amounts of bacterial DNA) display an increased α-diversity due to spurious OTUs. This highlights the need for careful interpretations of data from low biomass samples, e.g., from the skin of healthy controls with effective host defenses, where reagent and other contaminants may play a major role.
Skin mock community
Representative bacteria of six different genera have been isolated from the antecubital crease of healthy and atopic participants in an adult atopic eczema cohort at the dermatology hospital of the Technical University Munich. Isolated bacterial strains were purified by subculturing on TSA media. Stock suspensions were stored at – 80 °C after adding glycerol (10%). Bacteria were identified by microscopy, biochemical analysis using api® Staph / 20 NE strips (bioMérieux, Nürtingen, Germany), and MALDI-TOF.
To compare bacterial diversity between BDA and NDA-purified DNA, a skin mock community of ten strains was used (Table 1). The mock community was assembled by mixing concentrations of 107 CFU per strain each to establish a final mock community of 108 CFU (“live” mock community). To evaluate the ability of BDA to eliminate DNA from dead bacteria, P. aeruginosa and P. mirabilis were not added to the mix vital as in the live mock community but after a heat inactivation step of 1 h at 56 °C (“hi” mock community). Further, purified B. simplex DNA corresponding to 107 CFU was added to the hi mock community to assess the effectiveness of BDA in depleting free bacterial DNA reads (“hi DNA” mock community). Finally, we evaluated whether the BDA was able to remove host DNA reads from skin mock community samples by adding 105 peripheral blood mononuclear cells (PBMCs) to the hi DNA mock community.
To compare BDA with a more conventional DNA extraction approach (CA), four bacteria, namely Staphylococcus aureus, Micrococcus luteus, Corynebacterium pseudodiphtericum, and Moraxella osloensis were included in the skin mock community. The mock community was created by adding 2 × 107 CFU of each bacterium. Next, 2 × 107 CFU E. coli, either living or heat inactivated (56 °C for 1 h), or 58 ng of purified DNA (corresponding to 2 × 107 CFU) were spiked-in. In total, an undiluted mock community sample consisted of 1 × 108 CFU re-suspended in 1 ml 0.15 mM NaCl solution.
To examine low-DNA input samples, bacterial suspensions were prepared from 108 CFU, which were then diluted to 107, 105, or 103 CFU, respectively. Nuclease free water was used as control.
Human skin microbiome samples
Skin swabs were obtained from the arm fossa of a healthy volunteer by rubbing back and forth approximately 50 times and applying firm pressure using forensic 4N6FLOQ swabs (COPAN flock technologies, Brescia, Italy) moistened with 0.15 mM NaCl solution containing Tween 20 at 0.1% [64, 65]. Microbiota were released from swabs by swirling in 15 ml of NaCl solution at 0.15 mM. Skin microbiome samples were supplemented with heat-inactivated E. coli cells (1.4 × 106 CFU/sample) or its purified DNA (4.2 ng/sample corresponding to 1.4 × 106 CFU).
Microbial DNA was extracted from mock communities or skin microbiome swabs using a commercial microbiome DNA extraction kit and either including (BDA) or not including (NDA) a 30-min Benzonase pre-digest of unprotected DNA according to the manufacturer’s instructions (QIAamp DNA Microbiome kit; Qiagen, Hilden, Germany). Samples were extracted freshly to avoid bacterial lysis by freeze-thawing. An additional microbial DNA extraction method (CA), not designed to include a Benzonase digest (ZymoBIOMICS DNA miniprep kit; Zymo Research, Freiburg, Germany), was used for comparison (following the manufacturers’ protocol). Both kits use a combination of mechanical and chemical lysis to disrupt Gram-negative and Gram-positive bacteria. Bacterial DNA is purified through adsorption to silica membrane columns included in the kits, which have undergone a proprietary DNA decontamination process. The Maxwell® 16 LEV Blood DNA Kit (Promega, Fitchburg, WI) was used as a control method for host DNA preparation (human DNA preparation approach; HA). All DNA samples were suspended in 50 μl elution buffer. DNA concentrations were estimated using the Quantus fluorometer (Promega); human DNA was also quantified by real-time PCR using the human gDNA detection kit (Primer Design, Camberley, UK). DNA samples were stored at – 20° C until further processing.
16S rRNA gene amplification
The 16S rRNA gene-specific primers used for targeting the V3 and V4 regions were, forward: S-D-Bact-0341-b-S-17 (5’ → 3’) TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG CCT ACG GGN GGC WGC AG, and reverse: S-D-Bact-0785-a-A-21 (5’ → 3’) GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GGA CTA CHV GGG TAT CTA ATC C . To each 5 μl of extracted template DNA, 12.5 μL of a NEB Next High Fidelity Master Mix (New England Biolabs, Ipswich, MA), 0.5 μL of each forward and reverse primers (10 pmol/μl), and 6.5 μl of DEPC water were added. A first PCR was performed in two replicates for every sample as follows: 5 min at 98 °C, followed by 25 amplification cycles of 10 s at 98 °C, 30 s at 60 °C, 30 s at 72 °C, and finally 5 min at 72 °C. A second PCR was performed for dual indexing with Illumina adaptors from the Nextera XT Index Kit v2 Set B (Illumina, San Diego, CA). One microliter of purified amplicon sample (10 ng) was mixed with 2.5 μl of each Illumina index, 12.5 μl of the Next High Fidelity Master Mix, and 6.5 μl of DEPC water. PCR settings were 30 s at 98 °C, followed by 8 amplification cycles of 10 s at 98 °C, 30 s at 55 °C, 30 s at 72 °C, and a final heating step at 72 °C for 5 min . Indexed PCR products were purified using Ampure XP beads (Beckman Coulter, California, USA) and analyzed using Agilent DNA 7500 Chip (Agilent, Waldbronn, Germany). The DNA concentration was measured with QuantiFluor dsDNA System using a Quantus fluorometer (Promega). The sequencing library was prepared by pooling 4 nM of each purified sample equimolarly for sequencing on an Illumina MiSeq platform with a PE300 v3 cartridge (generating up to 25 million of 2 × 300 bp reads). The control samples did not generate measurable amounts of PCR amplicons and were, therefore, added to the pool using an equal volume instead. Final pools were spiked with 10% phiX.
Metagenomic library preparation
Metagenomic libraries were constructed using the NEBNext® Ultra™ II FS DNA Library Prep Kit for Illumina® (New England BioLabs). Dual indexing was conducted employing the NEBNext® Multiplex Oligos kit for Illumina® (Dual index primers set 1, New England BioLabs). Purification and size selection was performed based on Agencourt® AMPure® XP (Beckman-Coulter, MA, USA). Library inserts ranging from 250 to 400 bp were further evaluated using a Fragment Analyzer™ (Advanced Analytical, Ankeny, IA). Libraries were pooled equimolarly and 15 pM was spiked with 1% PhiX (Illumina). Sequencing was performed on an Illumina® NextSeq 550 (Illumina) using the paired-end mode (2 × 150 bp Mid output kit bp, Kit v2.5, 300 cycles).
Sequence analysis and statistics
Raw 16S rRNA gene amplicon sequencing reads were processed following the UPARSE method  as implemented in the online IMNGS platform . In brief, primer and barcode sequences were trimmed from each read, and sequences shorter than 200 bp were discarded. Clusters were formed de-novo at 97% similarity cutoff and the resulting OTUs were taxonomically classified by the RDB classifier . Downstream analysis of the OTU tables was performed using the R scripts available in the Rhea pipeline . Experiments were performed in triplicates. Group comparisons were made using Wilcoxon-Mann-Whitney test followed by the Benjamini-Hochberg post-hoc procedure for multiple comparisons.
For the metagenomics experiment, adapters and primers were removed from raw reads using Adapterremoval v2.1 . Reads with nucleotides with quality values less than 15 were trimmed at this position and sequences shorter than 50 bp discarded. Human DNA sequence reads were identified and removed using KneadData v0.35 (https://huttenhower.sph.harvard.edu/kneaddata/) with the Hg-19 human reference genome, and percentages were calculated. Taxonomy was obtained using MetaPhlAn v3.0, which uses a database of clade-specific markers to quantify bacteria constituents at the species and higher taxonomic levels. MetaPhlAn v3.0 was run using default settings .
Tables displaying read counts from 16S rRNA gene sequencing and metagenomics analyses, as well as initial DNA concentrations, have been included as Supplementary Data.
Availability of data and materials
OTU tables and metagenome read counts are available as supplementary files.
Benzonase digest approach
Conventional approach of microbial DNA preparation
- DEPC water:
Diethyl pyrocarbonate treated water
Human DNA preparation approach
Non-Benzonase digest approach
Operational taxonomic unit
Peripheral blood mononuclear cells
Ribosomal Database Project
Ribosomal RNA Database of Michigan University
Trypticase soy agar
Trypticase soy broth
Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, et al. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190–2. https://doi.org/10.1126/science.1171700.
Eyerich S, Eyerich K, Traidl-Hoffmann C, Biedermann T. Cutaneous barriers and skin immunity: differentiating a connected network. Trends Immunol. 2018;39(4):315–27. https://doi.org/10.1016/j.it.2018.02.004.
Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850–9. https://doi.org/10.1101/gr.131029.111.
Koberle M, Biedermann T. Microbiome, atopic eczema and blockade of type 2 immunity. Hautarzt. 2018;69(3):197–203. https://doi.org/10.1007/s00105-018-4129-2.
Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138(2):336–49. https://doi.org/10.1016/j.jaci.2016.06.010.
Tett A, Pasolli E, Farina S, Truong DT, Asnicar F, Zolfo M, et al. Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis. NPJ Biofilms Microbiomes. 2017;3(1):14. https://doi.org/10.1038/s41522-017-0022-5.
Fry L, Baker BS, Powles AV, Fahlen A, Engstrand L. Is chronic plaque psoriasis triggered by microbiota in the skin? Br J Dermatol. 2013;169(1):47–52. https://doi.org/10.1111/bjd.12322.
Fitz-Gibbon S, Tomida S, Chiu B-H, Nguyen L, Du C, Liu M, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Investig Dermatol. 2013;133(9):2152–60. https://doi.org/10.1038/jid.2013.21.
Kong HH, Andersson B, Clavel T, Common JE, Jackson SA, Olson ND, et al. Performing skin microbiome research: a method to the madness. J Invest Dermatol. 2017;137(3):561–8. https://doi.org/10.1016/j.jid.2016.10.033.
Aagaard K, Petrosino J, Keitel W, Watson M, Katancik J, Garcia N, et al. The human microbiome project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J. 2013;27(3):1012–22. https://doi.org/10.1096/fj.12-220806.
Schrader C, Schielke A, Ellerbroek L, Johne R. PCR inhibitors - occurrence, properties and removal. J Appl Microbiol. 2012;113(5):1014–26. https://doi.org/10.1111/j.1365-2672.2012.05384.x.
Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143–55. https://doi.org/10.1038/nrmicro.2017.157.
Castelino M, Eyre S, Moat J, Fox G, Martin P, Ho P, et al. Optimisation of methods for bacterial skin microbiome investigation: primer selection and comparison of the 454 versus MiSeq platform. BMC Microbiol. 2017;17(1):23. https://doi.org/10.1186/s12866-017-0927-4.
Feigelman R, Kahlert CR, Baty F, Rassouli F, Kleiner RL, Kohler P, et al. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Microbiome. 2017;5(1):20. https://doi.org/10.1186/s40168-017-0234-1.
Marotz CA, Sanders JG, Zuniga C, Zaramela LS, Knight R, Zengler K. Improving saliva shotgun metagenomics by chemical host DNA depletion. Microbiome. 2018;6(1):42. https://doi.org/10.1186/s40168-018-0426-3.
Horz HP, Scheer S, Vianna ME, Conrads G. New methods for selective isolation of bacterial DNA from human clinical specimens. Anaerobe. 2010;16(1):47–53. https://doi.org/10.1016/j.anaerobe.2009.04.009.
Goltsman DSA, Sun CL, Proctor DM, DiGiulio DB, Robaczewska A, Thomas BC, et al. Metagenomic analysis with strain-level resolution reveals fine-scale variation in the human pregnancy microbiome. Genome Res. 2018;28(10):1467–80. https://doi.org/10.1101/gr.236000.118.
Nelson MT, Pope CE, Marsh RL, Wolter DJ, Weiss EJ, Hager KR, et al. Human and extracellular DNA depletion for metagenomic analysis of complex clinical infection samples yields optimized viable microbiome profiles. Cell Rep. 2019;26(8):2227–2240.e2225. https://doi.org/10.1016/j.celrep.2019.01.091.
Beckers B, Op De Beeck M, Thijs S, Truyens S, Weyens N, Boerjan W, et al. Performance of 16s rDNA primer pairs in the study of rhizosphere and endosphere bacterial microbiomes in metabarcoding studies. Front Microbiol. 2016;7:650. https://doi.org/10.3389/fmicb.2016.00650.
Feehery GR, Yigit E, Oyola SO, Langhorst BW, Schmidt VT, Stewart FJ, et al. A method for selectively enriching microbial DNA from contaminating vertebrate host DNA. PLoS One. 2013;8(10):e76096. https://doi.org/10.1371/journal.pone.0076096.
Thoendel M, Jeraldo PR, Greenwood-Quaintance KE, Yao JZ, Chia N, Hanssen AD, et al. Comparison of microbial DNA enrichment tools for metagenomic whole genome sequencing. J Microbiol Methods. 2016;127:141–5. https://doi.org/10.1016/j.mimet.2016.05.022.
Carini P, Marsden PJ, Leff JW, Morgan EE, Strickland MS, Fierer N. Relic DNA is abundant in soil and obscures estimates of soil microbial diversity. Nat Microbiol. 2016;2:16242. https://doi.org/10.1038/nmicrobiol.2016.242.
Moreno JM, Sanchez-Montero JM, Sinisterra JV, Nielsen LB. Contribution to the study of the enzymatic activity of benzonase. J Mol Catal. 1991;69(3):419–27. https://doi.org/10.1016/0304-5102(91)80120-R.
Nestle M, Roberts WK. An extracellular nuclease from Serratia marcescens. II. Specificity of the enzyme. J Biol Chem. 1969;244(19):5219–25. https://doi.org/10.1016/S0021-9258(18)63649-X.
Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–53. https://doi.org/10.1038/nrmicro2537.
Ageitos JM, Sanchez-Perez A, Calo-Mata P, Villa TG. Antimicrobial peptides (AMPs): ancient compounds that represent novel weapons in the fight against bacteria. Biochem Pharmacol. 2017;133:117–38. https://doi.org/10.1016/j.bcp.2016.09.018.
Lazarevic V, Gaia N, Emonet S, Girard M, Renzi G, Despres L, et al. Challenges in the culture-independent analysis of oral and respiratory samples from intubated patients. Front Cell Infect Microbiol. 2014;4:65. https://doi.org/10.3389/fcimb.2014.00065.
Weyrich LS, Farrer AG, Eisenhofer R, Arriola LA, Young J, Selway CA, et al. Laboratory contamination over time during low-biomass sample analysis. Mol Ecol Resour. 2019;19(4):982–96. https://doi.org/10.1111/1755-0998.13011.
Biedermann T, Skabytska Y, Kaesler S, Volz T. Regulation of T cell immunity in atopic dermatitis by microbes: the yin and yang of cutaneous inflammation. Front Immunol. 2015;6. https://doi.org/10.3389/fimmu.2015.00353.
Kaesler S, Volz T, Skabytska Y, Köberle M, Hein U, Chen K-M, et al. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4–mediated suppression of IL-10. J Allergy Clin Immunol. 2014;134(1):92–99.e96. https://doi.org/10.1016/j.jaci.2014.02.017.
Skabytska Y, Wölbing F, Günther C, Köberle M, Kaesler S, Chen K-M, et al. Cutaneous innate immune sensing of toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Immunity. 2014;41(5):762–75. https://doi.org/10.1016/j.immuni.2014.10.009.
Volz T, Kaesler S, Draing C, Hartung T, Röcken M, Skabytska Y, et al. Induction of IL-10-balanced immune profiles following exposure to LTA from Staphylococcus epidermidis. Exp Dermatol. 2018;27(4):318–26. https://doi.org/10.1111/exd.13540.
Kim D, Hofstaedter CE, Zhao C, Mattei L, Tanes C, Clarke E, et al. Optimizing methods and dodging pitfalls in microbiome research. Microbiome. 2017;5(1):52. https://doi.org/10.1186/s40168-017-0267-5.
Glassing A, Dowd SE, Galandiuk S, Davis B, Chiodini RJ. Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples. Gut Pathog. 2016;8(1):24. https://doi.org/10.1186/s13099-016-0103-7.
Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014;12(1):87. https://doi.org/10.1186/s12915-014-0087-z.
Eder W, Wanner G, Ludwig W, Busse H-J, Ziemke-Kägeler F, Lang E. Description of Undibacterium oligocarboniphilum sp. nov., isolated from purified water, and Undibacterium pigrum strain CCUG 49012 as the type strain of Undibacterium parvum sp. nov., and emended descriptions of the genus Undibacterium and the species Undibacterium pigrum. Int J Syst Evol Microbiol. 2011;61(2):384–91. https://doi.org/10.1099/ijs.0.018648-0.
Velasquez-Mejia EP, de la Cuesta-Zuluaga J, Escobar JS. Impact of DNA extraction, sample dilution, and reagent contamination on 16S rRNA gene sequencing of human feces. Appl Microbiol Biotechnol. 2018;102(1):403–11. https://doi.org/10.1007/s00253-017-8583-z.
Caruso V, Song X, Asquith M, Karstens L. Performance of microbiome sequence inference methods in environments with varying biomass. mSystems. 2019;4(1):e00163–18. https://doi.org/10.1128/mSystems.00163-18.
Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 2019;27(2):105–17. https://doi.org/10.1016/j.tim.2018.11.003.
Williams MR, Gallo RL. The role of the skin microbiome in atopic dermatitis. Curr Allergy Asthma Rep. 2015;15(11):65. https://doi.org/10.1007/s11882-015-0567-4.
Huang YJ, Boushey HA. The microbiome in asthma. J Allergy Clin Immunol. 2015;135(1):25–30. https://doi.org/10.1016/j.jaci.2014.11.011.
Michail S, Durbin M, Turner D, Griffiths AM, Mack DR, Hyams J, et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis. 2011;18(10):1799–808. https://doi.org/10.1002/ibd.22860.
Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859–68. https://doi.org/10.1038/nm.4358.
Knight R, Callewaert C, Marotz C, Hyde ER, Debelius JW, McDonald D, et al. The microbiome and human biology. Annu Rev Genomics Hum Genet. 2017;18(1):65–86. https://doi.org/10.1146/annurev-genom-083115-022438.
Fu X, Zeng B, Wang P, Wang L, Wen B, Li Y, et al. Microbiome of total versus live bacteria in the gut of rex rabbits. Front Microbiol. 2018;9:733. https://doi.org/10.3389/fmicb.2018.00733.
Emerson JB, Adams RI, Roman CMB, Brooks B, Coil DA, Dahlhausen K, et al. Schrödinger’s microbes: tools for distinguishing the living from the dead in microbial ecosystems. Microbiome. 2017;5(1):86. https://doi.org/10.1186/s40168-017-0285-3.
Nakano T, Yoshino T, Fujimura T, Arai S, Mukuno A, Sato N, et al. Reduced expression of dermcidin, a peptide active against Propionibacterium acnes, in sweat of patients with acne vulgaris. Acta Derm Venereol. 2015;95(7):783–6. https://doi.org/10.2340/00015555-2068.
Cannavo SP, Guarneri F, Giuffrida R, Aragona E, Guarneri C. Evaluation of cutaneous surface parameters in psoriatic patients. Skin Res Technol. 2017;23(1):41–7. https://doi.org/10.1111/srt.12299.
Willis AL, Calton JB, Carr TF, Chiu AG, Chang EH. Dead or alive: Deoxyribonuclease I sensitive bacteria and implications for the sinus microbiome. Am J Rhinol Allergy. 2016;30(2):94–8. https://doi.org/10.2500/ajra.2016.30.4278.
Ramamurthy T, Ghosh A, Pazhani GP, Shinoda S. Current perspectives on viable but non-culturable (VBNC) pathogenic bacteria. Front Public Health. 2014;2. https://doi.org/10.3389/fpubh.2014.00103.
Stinson LF, Keelan JA, Payne MS. Characterization of the bacterial microbiome in first-pass meconium using propidium monoazide (PMA) to exclude nonviable bacterial DNA. Lett Appl Microbiol. 2019;68(5):378–85. https://doi.org/10.1111/lam.13119.
Nogva HK, Dromtorp SM, Nissen H, Rudi K. Ethidium monoazide for DNA-based differentiation of viable and dead bacteria by 5’-nuclease PCR. Biotechniques. 2003;34(4):804–808, 810, 812-803. https://doi.org/10.2144/03344rr02.
Soejima T, Iida K, Qin T, Taniai H, Seki M, Takade A, et al. Photoactivated ethidium monoazide directly cleaves bacterial DNA and is applied to PCR for discrimination of live and dead bacteria. Microbiol Immunol. 2007;51(8):763–75. https://doi.org/10.1111/j.1348-0421.2007.tb03966.x.
Fittipaldi M, Nocker A, Codony F. Progress in understanding preferential detection of live cells using viability dyes in combination with DNA amplification. J Microbiol Methods. 2012;91(2):276–89. https://doi.org/10.1016/j.mimet.2012.08.007.
Nocker A, Cheung CY, Camper AK. Comparison of propidium monoazide with ethidium monoazide for differentiation of live vs. dead bacteria by selective removal of DNA from dead cells. J Microbiol Methods. 2006;67(2):310–20. https://doi.org/10.1016/j.mimet.2006.04.015.
Pan Y, Breidt F Jr. Enumeration of viable Listeria monocytogenes cells by real-time PCR with propidium monoazide and ethidium monoazide in the presence of dead cells. Appl Environ Microbiol. 2007;73(24):8028–31. https://doi.org/10.1128/AEM.01198-07.
Yanez MA, Nocker A, Soria-Soria E, Murtula R, Martinez L, Catalan V. Quantification of viable Legionella pneumophila cells using propidium monoazide combined with quantitative PCR. J Microbiol Methods. 2011;85(2):124–30. https://doi.org/10.1016/j.mimet.2011.02.004.
Gedalanga PB, Olson BH. Development of a quantitative PCR method to differentiate between viable and nonviable bacteria in environmental water samples. Appl Microbiol Biotechnol. 2009;82(3):587–96. https://doi.org/10.1007/s00253-008-1846-y.
Vaishampayan P, Probst AJ, La Duc MT, Bargoma E, Benardini JN, Andersen GL, et al. New perspectives on viable microbial communities in low-biomass cleanroom environments. ISME J. 2013;7(2):312–24. https://doi.org/10.1038/ismej.2012.114.
Llamas B, Valverde G, Fehren-Schmitz L, Weyrich LS, Cooper A, Haak W. From the field to the laboratory: controlling DNA contamination in human ancient DNA research in the high-throughput sequencing era. STAR. 2017;3(1):1–14. https://doi.org/10.1080/20548923.2016.1258824.
Stinson LF, Keelan JA, Payne MS. Identification and removal of contaminating microbial DNA from PCR reagents: impact on low-biomass microbiome analyses. Lett Appl Microbiol. 2019;68(1):2–8. https://doi.org/10.1111/lam.13091.
Nguyen NH, Smith D, Peay K, Kennedy P. Parsing ecological signal from noise in next generation amplicon sequencing. New Phytol. 2015;205(4):1389–93. https://doi.org/10.1111/nph.12923.
Thomas Clavel, Sandra Reitmeier, Thomas CA Hitch et al. Handling of Spurious Sequences Affects the Outcome of High-Throughput 16S rRNA Gene Amplicon Profiling, PREPRINT (Version 1) available at Research Square. 2020. https://doi.org/10.21203/rs.3.rs-117421/v1.
Zeeuwen PL, Boekhorst J, van den Bogaard EH, de Koning HD, van de Kerkhof PM, Saulnier DM, et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol. 2012;13(11):R101. https://doi.org/10.1186/gb-2012-13-11-r101.
Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG, Blakesley RW, et al. A diversity profile of the human skin microbiota. Genome Res. 2008;18(7):1043–50. https://doi.org/10.1101/gr.075549.107.
Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41(1):e1. https://doi.org/10.1093/nar/gks808.
Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–8. https://doi.org/10.1038/nmeth.2604.
Lagkouvardos I, Joseph D, Kapfhammer M, Giritli S, Horn M, Haller D, et al. IMNGS: a comprehensive open resource of processed 16S rRNA microbial profiles for ecology and diversity studies. Sci Rep. 2016;6(1):33721. https://doi.org/10.1038/srep33721.
Wang Q, Garrity GM, Tiedje JM, Cole JR. Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261–7. https://doi.org/10.1128/AEM.00062-07.
Lagkouvardos I, Fischer S, Kumar N, Clavel T. Rhea: a transparent and modular R pipeline for microbial profiling based on 16S rRNA gene amplicons. PeerJ. 2017;5:e2836. https://doi.org/10.7717/peerj.2836.
Schubert M, Lindgreen S, Orlando L. AdapterRemoval v2: rapid adapter trimming, identification, and read merging. BMC Res Notes. 2016;9(1):88. https://doi.org/10.1186/s13104-016-1900-2.
Beghini F, McIver LJ, Blanco-Míguez A, Dubois L, Asnicar F, Maharjan S, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. bioRxiv 2020.11.19.388223. https://doi.org/10.1101/2020.11.19.388223.
We thank Alphina Kain for English language editing.
This work was supported by grants from Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) to T. Biedermann INST411/66-1 FUGG, CRC 824 B10, CRC 1335 P17, CRC 1371 P06; bilateral funding from Luxembourg National Research Fund (FNR) project C17/BM/11656090 – DFG DACH-Lead-Agency BI696/12-1 and by BMBF, Helmholtz-Gemeinschaft: Unit clinical allergology to characterize the genesis and termination of atopic dermatitis. M. Köberle has received funding from BMWi (IGF Vorhaben Nr. 20122N). Open Access funding enabled and organized by Projekt DEAL.
Ethics approval and consent to participate
Skin swabs were obtained with the consent of the participants. Sampling of the human skin microbiome in this study has been approved by the Regierung von Oberbayern (473/16 S).
Consent for publication
The authors declare that the research was conducted in the absence of any conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Benzonase digest approach efficiently depletes dead bacteria and free bacterial DNA reads. Microbial DNA was extracted using a conventional approach (CA) or the benzonase-digest approach (BDA) before bacterial lysis. a) Microbiome analysis of a skin mock community supplemented with live E. coli cells, heat inactivated (hi) E. coli cells or E. coli free DNA. b) Relative abundance reads resulting from E. coli in the mock community. c) Microbiome analysis at genus level of forearm skin samples spiked with hi E. coli or E. coli free DNA. d) Relative abundance of E. coli reads in spiked skin samples. P valued were calculated using Wilcoxon-Mann-Whitney test. * p ≤ 0.05, ** p ≤ 0.01, *** p≤ 0.001.
Benzonase digest approach efficiently depletes dead bacteria and host DNA reads with no impact on microbiota composition. a) DNA yields from a skin mock community supplemented with 3×105 PBMCs/sample and processed with different extraction methods: HA (Human blood kit), CA (conventional approach for bacteria DNA extraction) and the BDA (benzonase digest approach). b) Real-time PCR plot of human DNA reads corresponding to the mock community supplemented with PBMCs extracted using different approaches. c) The principal coordinate analysis plot (PCoA) of β-diversity shows the ability of BDA to eliminate human DNA reads from PBMCs as well as DNA from heat inactivated bacterial cells (from P. aeruginosa and P. mirabilis) and free bacterial DNA (B. simplex). BDA (benzonase-digest approach), NDA (non-benzonase-digest approach). PBMCs (human peripheral blood mono nuclear cells). Live (mock community comprising living bacteria), hi (heat inactivated P. aeruginosa and P. mirabilis), DNA (free DNA from B. simplex).
Benzonase digest approach efficiently depletes dead bacteria and host DNA from metagenomics reads. a) Metagenomics read counts from skin mock community samples (hi, DNA), supplemented or not with 105 PBMCs and processed either with BDA or NDA. b) Human and bacteria metagenomics read counts in mock community samples (hi, DNA). c) Relative abundance of OTUs detected in metagenomics reads. d) Relative abundance of OTUs obtained from skin mock community supplemented or not with human PBMCs. The taxonomy analysis based on metagenomics data has been performed using MetaPhlAn 3.0 tool. BDA (Benzonase-digest approach), NDA (Non-Benzonase-digest approach). PBMCs (human peripheral blood mono nuclear cells). OTUs (Operational taxonomic units), hi, DNA (Skin mock community with heat inactivated P. aeruginosa and P. mirabilis and free bacterial DNA from B. simplex).
The Benzonase approach generates less diversity bias compared to CA in low bacterial DNA input samples. The mock community of living bacteria (108 CFU/sample) was diluted to 107, 105 and 103 CFU/sample and then DNA extracted by the CA or the BDA. Taxonomic binning of bacterial taxa in samples processed by a) BDA or b) CA. c, d) Richness e, f) Shannon effective and g, h) β-diversity analysis of the mock community after dilution and extraction using BDA or CA. BDA (Benzonase digest approach), CA (conventional approach). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
Abundant OTUs in the Benzonase digest approach (BDA) upon dilution (OTUs used to constitute the mock community in bold letters). Supplementary table 02. Abundant OTUs in the Non-Benzonase digest approach (NDA) upon dilution (OTUs used to constitute the mock community in bold letters). Supplementary table 03. Abundant OTUs (> 1%) in the benzonase digest approach (BDA) upon dilution (small mock community, OTUs used to constitute the mock community in bold letters). Supplementary table 04. Abundant OTUs (> 1%) in the conventional approach (CA) upon dilution (small mock community, OTUs used to constitute the mock community in bold letters).
16S rRNA gene amplicon reads per sample after every processing step. Table 02. Metagenomics reads per sample after every processing step. Table 03. Metagenomics based taxa relative abundances. Table 04. Metagenomics based taxa relative abundances in sampled containing PBMCs.
About this article
Cite this article
Amar, Y., Lagkouvardos, I., Silva, R.L. et al. Pre-digest of unprotected DNA by Benzonase improves the representation of living skin bacteria and efficiently depletes host DNA. Microbiome 9, 123 (2021). https://doi.org/10.1186/s40168-021-01067-0
- DNA extraction
- Next-generation sequencing
- Skin microbiome
- 16S rRNA
- Low biomass